Cargando…
Identification and Characterization of ZEL-H16 as a Novel Agonist of the Histamine H(3) Receptor
The histamine H3 receptor (H3R) has been recognized as a promising target for the treatment of various central and peripheral nervous system diseases. In this study, a non-imidazole compound, ZEL-H16, was identified as a novel histamine H3 receptor agonist. ZEL-H16 was found to bind to human H3R wit...
Autores principales: | Shi, Ying, Sheng, Rong, Zhong, Tingting, Xu, Yu, Chen, Xiaopan, Yang, Dong, Sun, Yi, Yang, Fenyan, Hu, Yongzhou, Zhou, Naiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411647/ https://www.ncbi.nlm.nih.gov/pubmed/22870296 http://dx.doi.org/10.1371/journal.pone.0042185 |
Ejemplares similares
-
Correction: Identification and Characterization of ZEL-H16 as a Novel Agonist of the Histamine H(3) Receptor
por: Shi, Ying, et al.
Publicado: (2012) -
Cardiovascular effects of H(3) histamine receptor inverse agonist/ H(4) histamine receptor agonist, clobenpropit, in hemorrhage-shocked rats
por: Wanot, Bartosz, et al.
Publicado: (2018) -
Design, synthesis, and anticonvulsant effects evaluation of nonimidazole histamine H(3) receptor antagonists/inverse agonists containing triazole moiety
por: Song, Mingxia, et al.
Publicado: (2020) -
Histamine therapeutic efficacy in metastatic melanoma: Role of histamine H(4) receptor agonists and opportunity for combination with radiation
por: Massari, Noelia A., et al.
Publicado: (2017) -
Structural insights into the agonists binding and receptor selectivity of human histamine H(4) receptor
por: Im, Dohyun, et al.
Publicado: (2023)